Creation of Pure Nanodrugs and Their Anticancer Properties
- 11 September 2012
- journal article
- Published by Wiley in Angewandte Chemie
- Vol. 51 (41), 10315-10318
- https://doi.org/10.1002/anie.201204596
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on sizeNature Nanotechnology, 2011
- Marked therapeutic efficacy of a novel polyethylene glycol-SN38 conjugate, EZN-2208, in xenograft models of B-cell non-Hodgkin's lymphomaHaematologica, 2009
- New Method for Delivering a Hydrophobic Drug for Photodynamic Therapy Using Pure Nanocrystal Form of the DrugMolecular Pharmaceutics, 2007
- Novel SN-38–Incorporating Polymeric Micelles, NK012, Eradicate Vascular Endothelial Growth Factor–Secreting Bulky TumorsCancer Research, 2006
- Nanosizing: a formulation approach for poorly-water-soluble compoundsEuropean Journal of Pharmaceutical Sciences, 2003
- Crystal Structures of Human Topoisomerase I in Covalent and Noncovalent Complexes with DNAScience, 1998
- Nanosuspensions for the formulation of poorly soluble drugs: I. Preparation by a size-reduction techniqueInternational Journal of Pharmaceutics, 1998
- Partial Purification and Characterization of an Esterase Acting on the Anticancer Pro-drugs, 7-Ethylcamptothecin Derivatives.Biological & Pharmaceutical Bulletin, 1995
- Synthesis and Antitumor Activity of 20(S)-Camptothecin Derivatives: Carbamate-Linked, Water-Soluble Derivatives of 7-Ethyl-10-hydroxycamptothecin.CHEMICAL & PHARMACEUTICAL BULLETIN, 1991
- Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2Journal of the American Chemical Society, 1966